Sundhedssektoren dækker alt fra forskning over medicin til sundhedssystemer. Sektoren kan opdeles i to kategorier: “Health Care Equipment and Services” - også kaldet “medico” - og “Pharmaceuticals, Biotechnology & Life Sciences”. Medicoindustrien består af selskaber, der udvikler, producerer og sælger medicinsk udstyr, mens “Pharmaceuticals, Biotechnology & Life Sciences”-kategorien består af store medicinalvirksomheder og biotekvirksomheder, der producerer forskellige former for lægemidler og medicinalvarer. I Danmark har vi en særligt veludviklet medicinalindustri med mange børsnoterede virksomheder, der både er veldrevne og sunde. Sundhedssektoren rummer store investeringsmuligheder, uanset om man er til defensive, langsigtede og sikre selskaber eller de nye og mere risikable selskaber med stort kurspotentiale.
Regnet på de 211 aktier i listen — som percentiler målt mod alle de aktier vi følger, ikke som karakterer. Genberegnes hver dag efter børslukning.
Hvad tallene siger i dag: Kvalitet: lav · Værdi: lav · Momentum: middel — målt som percentiler mod alle de aktier vi følger, ikke som karakterer. Flertallet af aktierne handler over deres egne gennemsnit lige nu. Spændet er stort — kvalitet går fra 0 til 99, så gennemsnittet dækker over meget forskellige selskaber.
| Aktie | Land | Kurs | Ændring |
|---|---|---|---|
| Bavarian Nordic A/S | Danmark | 251,20 | +1,54% |
| H Lundbeck A/S | Danmark | 48,85 | -0,51% |
| H Lundbeck A/S | Danmark | 52,45 | +0,67% |
| Arjo AB (publ) | Sverige | 34,12 | +1,13% |
| Orion Oyj | Finland | 96,35 | +4,39% |
| Universal Health Services, Inc | USA | 185,71 | -0,63% |
| Bristol-Myers Squibb Company | USA | 61,61 | +0,21% |
| Humana AB (publ) | Sverige | 70,60 | +0,43% |
| Medtronic plc | USA | 94,79 | 0,00% |
| Amphastar P | USA | 25,47 | 0,00% |
| UCB SA | Belgien | 270,30 | -0,88% |
| Siemens Healthineers AG | Tyskland | 42,29 | +1,03% |
| Regeneron Pharmaceuticals, Inc | USA | 807,67 | +0,33% |
| Amgen Inc | USA | 444,63 | +1,22% |
| Haleon PLC | Storbritannien | 380,20 | -0,26% |
| Ambea AB | Sverige | 185,50 | +2,04% |
| QIAGEN N.V | USA | 50,37 | -0,04% |
| Novo Nordisk A/S | USA | 39,13 | +0,20% |
| Merck KGaA | Tyskland | 143,60 | +0,21% |
| Pfizer Inc | USA | 29,79 | -0,80% |
| UnitedHealth Group Incorporated | USA | 410,70 | -1,77% |
| Attendo AB (publ) | Sverige | 117,70 | +2,53% |
| Synsam AB | Sverige | 56,20 | +0,90% |
| Getinge AB ser. B | Sverige | 268,00 | +0,11% |
| Halozyme Therapeutics, Inc | USA | 128,01 | 0,00% |
| Thermo Fisher Scientific Inc | USA | 684,89 | +1,64% |
| Demant A/S | Danmark | 360,60 | +0,45% |
| Ascendis Pharma A/S | USA | 245,15 | 0,00% |
| Danaher Corporation | USA | 232,96 | +1,07% |
| Zealand Pharma A/S | Danmark | 223,30 | -1,19% |
| Eli Lilly and Company | USA | 1.279,14 | +0,45% |
| Roche Holding AG | Schweiz | 321,50 | +0,25% |
| SCHOTT Pharma AG & Co. KGaA | Tyskland | 25,50 | -0,78% |
| Novo Nordisk A/S | Danmark | 260,45 | +0,12% |
| Globus Medical, Inc | USA | 81,86 | +0,55% |
| Biogen Inc | Tyskland | 166,36 | +2,98% |
| Bonesupport Holding AB | Sverige | 339,00 | +1,92% |
| InMode Ltd | USA | 13,72 | 0,00% |
| Royalty Pharma plc | USA | 64,76 | +1,41% |
| DaVita Inc. | Storbritannien | 184,70 | -0,82% |
| Agilent Technologies, Inc | USA | 175,95 | +1,66% |
| IQVIA Holdings Inc | USA | 274,30 | -1,81% |
| Sanofi ADR | USA | 41,79 | +0,46% |
| Viatris Inc | USA | 18,29 | +1,61% |
| Vertex Pharmaceuticals Incorporated | USA | 517,49 | -1,23% |
| HCA Healthcare, Inc | USA | 465,26 | 0,00% |
| Drägerwerk AG & Co. KGaA | Tyskland | 73,80 | +0,55% |
| AbbVie Inc | USA | 286,74 | -0,01% |
| Centene Corporation | USA | 68,03 | -3,05% |
| Henry Schein, Inc | USA | 84,51 | 0,00% |
| Novartis AG | USA | 153,81 | 0,00% |
| AstraZeneca PLC | Sverige | 1.708,00 | +0,92% |
| BioGaia AB (publ) | Sverige | 124,50 | -2,20% |
| Humana Inc | USA | 417,22 | +0,03% |
| Veeva Systems Inc | USA | 318,18 | -1,50% |
| DaVita HealthCare Partners Inc | USA | 184,03 | 0,00% |
| Johnson & Johnson | USA | 266,30 | 0,00% |
| CellaVision AB | Sverige | 171,00 | +0,71% |
| ALK-Abelló A/S | Danmark | 241,80 | -0,41% |
| ChemoMetec A/S | Danmark | 609,50 | +2,87% |
| Genmab A/S | Danmark | 2.964,00 | +12,10% |
| McKesson Corporation | USA | 992,87 | 0,00% |
| Camurus AB | Sverige | 667,50 | +0,23% |
| Illumina, Inc | USA | 271,04 | 0,00% |
| Cardinal Health, Inc | USA | 251,54 | 0,00% |
| argenx SE | Belgien | 780,20 | -0,26% |
| ICON PLC | USA | 183,78 | 0,00% |
| Coloplast A/S | Danmark | 480,40 | -0,89% |
| Swedish Orphan Biovitrum AB (publ) | Sverige | 459,00 | +1,06% |
| argenx SE | USA | 869,33 | 0,00% |
| Biogen Inc | USA | 252,26 | 0,00% |
| Krystal Biotech, Inc | USA | 313,66 | +0,69% |
| Carl Zeiss Meditec AG | Tyskland | 35,52 | -0,22% |
| BeiGene, Ltd. | USA | 370,87 | -1,79% |
| Ambu A/S | Danmark | 80,50 | +1,51% |
| Intuitive Surgical, Inc | USA | 446,00 | -1,39% |
| Tactile Systems Technology, Inc | USA | 23,39 | -1,06% |
| Almirall, S.A | Spanien | 10,40 | +0,39% |
| Sectra AB (publ) | Sverige | 336,40 | +0,06% |
| Boston Scientific Corporation | USA | 45,58 | 0,00% |
| Alcon Inc | USA | 69,99 | -0,26% |
| Abbott Laboratories | USA | 104,89 | +1,15% |
| Gilead Sciences, Inc | USA | 158,69 | 0,00% |
| Embla Medical hf | Danmark | 27,15 | +2,26% |
| GN Store Nord A/S | Danmark | 111,85 | -0,22% |
| Laboratorios Farmaceuticos Rovi, S.A | Spanien | 61,40 | +2,08% |
| Teva Pharma Industries Ltd ADR | USA | 39,95 | +1,37% |
| BICO Group AB | Sverige | 24,05 | 0,00% |
| Elekta AB (publ) | Sverige | 58,50 | +1,56% |
| Harvard Bioscience, Inc | USA | 8,32 | 0,00% |
| Eton Pharmaceuticals, Inc | USA | 50,17 | 0,00% |
| Omeros Corporation | USA | 16,29 | -1,69% |
| Xeris Pharmaceuticals, Inc | USA | 10,21 | +0,10% |
| Paxman AB | Sverige | 66,30 | +3,43% |
| Sprint Bioscience AB | Sverige | 3,45 | +3,29% |
| Dynavox Group | Sverige | 71,15 | -0,07% |
| Bruker Corporation | USA | 58,23 | 0,00% |
| Photocure ASA | Norge | 49,60 | +1,22% |
| Bayer AG NA | Tyskland | 45,56 | +3,59% |
| Swedencare publ AB | Sverige | 19,20 | -2,54% |
| RaySearch Laboratories AB (publ) | Sverige | 192,70 | +0,42% |
| Galmed Pharmaceuticals Ltd | USA | 3,62 | +4,69% |
| Insulet Corporation | USA | 149,26 | 0,00% |
| Merck & Co., Inc | USA | 140,60 | -3,21% |
| Ottobock SE & Co. KGaA | Tyskland | 49,05 | -0,51% |
| GRAIL, LLC | USA | 139,91 | +5,55% |
| ArcticZymes Technologies ASA | Norge | 20,50 | +0,99% |
| BioMarin Pharmaceutical Inc | USA | 55,75 | 0,00% |
| Teladoc Inc | USA | 6,24 | -1,58% |
| BrainCool AB | Sverige | 1,07 | +7,20% |
| Iovance Biotherapeutics, Inc | USA | 13,89 | -1,42% |
| Asker Healthcare Group AB | Tyskland | 6,41 | +0,31% |
| Sarepta Therapeutics, Inc | USA | 17,98 | +1,41% |
| Nanexa AB | Sverige | 10,52 | -1,31% |
| Moderna, Inc | USA | 198,69 | -0,70% |
| Sagimet Biosciences Inc. Series A Common Stock | USA | 9,56 | -0,21% |
| AbCellera Biologics Inc | USA | 12,08 | 0,00% |
| Aurora Cannabis Inc | USA | 3,90 | +0,52% |
| Vitrolife AB | Sverige | 108,90 | +0,09% |
| PDS Biotechnology Corporation | USA | 1,07 | -4,05% |
| Cantargia AB | Sverige | 1,38 | 0,00% |
| Infant Bacterial Therapeutics AB (publ) | Sverige | 75,70 | -7,12% |
| Personalis, Inc | USA | 15,88 | +0,19% |
| Saniona AB | Sverige | 11,17 | +1,27% |
| Moberg Pharma AB (publ) | Sverige | 11,08 | +0,73% |
| Pharma Equity Group A/S Cl A | Danmark | 0,08 | +5,12% |
| Revenio Group Oyj | Finland | 10,54 | -0,57% |
| So-Young International Inc | USA | 2,12 | +0,47% |
| Scandinavian Medical Solutions A/S | Danmark | 2,80 | +12,00% |
| Revolution Medicines, Inc | USA | 183,90 | -1,65% |
| BioArctic AB (publ) | Sverige | 308,20 | +2,73% |
| Circio Holding ASA | Norge | 11,24 | +3,69% |
| Tempus AI, Inc. Class A Common Stock | USA | 67,16 | -0,67% |
| Tilray, Inc | USA | 2,72 | -3,20% |
| Mendus AB (publ) | Sverige | 5,49 | -1,96% |
| SoftOx Solutions AS | Norge | 0,11 | -1,62% |
| Novavax, Inc | USA | 9,40 | -3,09% |
| Cybin Inc. Common Stock | USA | 10,36 | +1,67% |
| CRISPR Therapeutics AG | USA | 49,01 | 0,00% |
| Zomedica Corp. | USA | 0,08 | -5,73% |
| Fate Therapeutics, Inc | USA | 2,06 | 0,00% |
| BioNTech SE | USA | 86,86 | 0,00% |
| Canopy Growth Corporation | USA | 0,67 | -1,17% |
| ExpreS2ion Biotech Holding AB | Sverige | 0,99 | -5,71% |
| Hansa Biopharma AB | Sverige | 36,66 | -0,38% |
| BioPorto A/S | Danmark | 1,03 | +3,62% |
| Filana Therapeutics, Inc. | USA | 0,61 | -3,73% |
| Acrivon Therapeutics Inc. Common Stock | USA | 1,72 | -0,58% |
| Century Therapeutics, Inc. Common Stock | USA | 1,42 | -2,74% |
| Butterfly Network, Inc. | USA | 6,65 | -1,63% |
| COMPASS Pathways plc | USA | 11,05 | -1,16% |
| Immunitybio Inc | USA | 7,81 | -4,99% |
| Evaxion Biotech A/S | USA | 3,08 | -18,09% |
| Geron Corporation | USA | 1,15 | 0,00% |
| Recursion Pharmaceuticals, Inc | USA | 3,80 | +2,70% |
| Alvotech SDB | Sverige | 45,55 | -1,09% |
| Arcturus Therapeutics Holdings Inc | USA | 9,91 | 0,00% |
| Editas Medicine, Inc | USA | 2,40 | 0,00% |
| CG Oncology Inc. Common stock | USA | 61,56 | -0,24% |
| GH RESEARCH PLC DL-025 | Tyskland | 17,00 | +6,25% |
| Nano-X Imaging Ltd | USA | 0,35 | -6,04% |
| Alzinova AB | Sverige | 0,42 | -1,65% |
| Heron Therapeuti | USA | 0,30 | 0,00% |
| Vir Biotechnology, Inc | USA | 11,04 | +4,45% |
| BioInvent International AB | Sverige | 20,50 | +1,23% |
| XSpray Pharma AB | Sverige | 10,32 | +0,78% |
| Co-Diagnostics, Inc | USA | 0,55 | 0,00% |
| AC Immune SA | USA | 2,31 | -4,55% |
| Initiator Pharma A/S | Sverige | 2,24 | -5,49% |
| Monsenso A/S | Danmark | 0,23 | +15,00% |
| Denali Therapeutics Inc | USA | 18,66 | 0,00% |
| GH Research PLC | USA | 19,18 | +6,14% |
| Acarix A/S | Sverige | 0,19 | -0,21% |
| Q linea AB | Sverige | 15,70 | -1,57% |
| Gubra A/S | Danmark | 285,20 | -1,31% |
| Summit Therapeutics Inc | USA | 14,50 | -6,27% |
| StenoCare A/S | Danmark | 0,69 | -1,15% |
| Pila Pharma AB | Sverige | 1,54 | +6,60% |
| Dianthus Therapeutics Inc. | USA | 79,33 | +3,32% |
| Gossamer Bio, Inc | USA | 9,15 | -4,74% |
| Qlife Holding AB | Sverige | 1,04 | -5,78% |
| Fluoguide AS | Sverige | 30,00 | -4,76% |
| ViroGates A/S | Danmark | 7,65 | -8,93% |
| Viking Therapeutics, Inc | USA | 24,21 | -0,78% |
| Axsome Therapeutics, Inc | USA | 144,06 | 0,00% |
| Thor Medical ASA | Norge | 4,16 | -1,07% |
| Anavex Life Sciences Corp | USA | 1,28 | 0,00% |
| Corbus Pharmaceuticals Holdings, Inc | USA | 3,99 | 0,00% |
| Tenaya Therapeutics Inc. Common Stock | USA | 0,41 | +5,04% |
| Structure Therapeutics Inc. American Depositary Shares | USA | 21,10 | -0,42% |
| Immunic, Inc | USA | 7,28 | 0,00% |
| Altimmune, Inc | USA | 2,05 | -3,30% |
| Sana Biotechnology, Inc | USA | 2,36 | +1,29% |
| DBV Technologies S.A | Frankrig | 1,79 | +0,11% |
| AIM ImmunoTech Inc | USA | 0,17 | +7,81% |
| Valerio Therapeutics | Frankrig | 0,40 | -1,00% |
| Passage Bio, Inc | USA | 3,36 | -0,33% |
| Northwest Biotherapeutics, Inc | USA | 0,17 | +11,67% |
| Oncopeptides AB | Sverige | 1,67 | -1,18% |
| Inovio Pharmaceuticals, Inc | USA | 0,87 | -3,36% |
| Xintela AB | Sverige | 0,17 | -6,23% |
| Lifecare AS | Norge | 0,45 | +20,48% |
| Cardiff Oncology, Inc | USA | 0,80 | -11,62% |
| Faron Pharmaceuticals Oy | Finland | 0,38 | -0,40% |
| Biomea Fusion, Inc | USA | 0,64 | +5,92% |
| Bullfrog AI Holdings, Inc. Common Stock | USA | 0,48 | -2,59% |
| 2cureX AB | Sverige | 0,42 | -12,13% |
| Ocugen, Inc | USA | 0,71 | -3,58% |
| Aptevo Therapeutics Inc | USA | 1,50 | -6,83% |
| Xeris Biopharma Holdings, Inc. | Storbritannien | 10,20 | -0,19% |
| CRISPR Therapeutics AG | Storbritannien | 49,61 | +0,77% |